Inhibition of acetaminophen hepatotoxicity by chlorpromazine in fed and fasted mice.
Acetaminophen hepatotoxicity has been shown previously to be potentiated by fasting, and the mechanism of hepatotoxicity has been correlated with depletion of reduced glutathione and the resulting elevation of cytosolic calcium. Chlorpromazine inhibited the hepatotoxicity of acetaminophen in a dose-dependent manner in fed and fasted mice. A 6 mg/kg dose of chlorpromazine prevented the acetaminophen-promoted increase in SGPT levels and prevented hepatic necrosis. Chlorpromazine did not prevent the depletion of reduced glutathione by acetaminophen in fed or fasted mice, although it did decrease the extent of reduced glutathione depletion caused by acetaminophen in fed mice from 80% depletion to 67% depletion. We propose that chlorpromazine causes a negative sensitivity modulation to calcium in hepatocytes, as evidenced by chlorpromazine preventing the acetaminophen-stimulated rise in phosphorylase a activity. We also propose that fasting potentiates acetaminophen hepatotoxicity by causing a positive sensitivity modulation to calcium in hepatocytes via the actions of glucagon.
Saville
J G
JG
Department of Pharmacal Sciences, School of Pharmacy, Auburn University, AL 36849.
Davidson
C P
CP
D'Adrea
G H
GH
Born
C K
CK
Hamrick
M E
ME
D000082:Acetaminophen / Q000633:toxicity*; D000818:Animals; D002118:Calcium / Q000378:metabolism; D002746:Chlorpromazine / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D005215:Fasting; D005934:Glucagon / Q000378:metabolism; D005978:Glutathione / Q000032:analysis; D008099:Liver / Q000187:drug effects*; D008297:Male; D051379:Mice; D010762:Phosphorylase a / Q000032:analysis
D000082:Acetaminophen; D005934:Glucagon; D010762:Phosphorylase a; D005978:Glutathione; D002118:Calcium; D002746:Chlorpromazine